Medical Properties Trust Inc.

MPW | NYSE

Price Alert Chart Builder DCF Calculator

$5.36

+$0.08 (+1.52%)

Feb 06, 2026, 09:30 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $3.22B

Enterprise Value $2.92B

Beta 1.46

Average Volume N/A

Shares Outstanding (Diluted) 597.96M

Shares Change YoY -0.46%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 0.4%

1Y CAGR (ann.) 13.8%

5Y CAGR (ann.) -18.6%

All-Time CAGR 4.0%

Valuation

PE Ratio 974.55

Forward PE 36.09

PEG Ratio 1.46

Forward PEG 17.34

PS Ratio 4.03

Forward PS 3.10

PB Ratio 0.72

P/FCF Ratio -61.84

P/Adj. FCF Ratio -216.55

P/OCF Ratio -59.56

EV/Sales 3.66

EV/EBIT 14.26

EV/EBITDA 6.01

EV/FCF -56.07

Earnings Yield 0.1%

FCF Yield -1.6%

Adj. FCF Yield -0.5%

Financial Health

Net Cash $300.85M

Total Debt $95.71M

Cash & Short-Term Investments $396.56M

Total Assets $14.75B

Current Ratio 11.91

Quick Ratio 11.91

Debt / Equity Ratio 0.02

Debt / EBITDA 0.20

Debt / FCF -1.84

OCF / Debt -0.54

Interest Coverage 0.50

Altman Z-Score -0.01

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 24.2%

Operating Profit Margin 15.5%

EBITDA Margin 60.8%

Net Profit Margin 0.4%

FCF Margin -6.5%

Adj. FCF Margin -1.9%

SBC / Revenue -4.7%

SBC Impact (per share) -71.4%

Returns

Return on Assets 0.0%

Return on Equity 0.1%

Return on Invested Capital 0.0%

Return on Capital Employed 0.8%

Return on Tangible Assets 0.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -18.2%

Revenue CAGR 5Y -11.0%

Revenue CAGR 10Y 4.7%

EPS CAGR 3Y -64.2%

EPS CAGR 5Y -64.1%

EPS CAGR 10Y -39.2%

FCF CAGR 3Y -126.7%

FCF CAGR 5Y -54.3%

FCF CAGR 10Y 7.3%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 28

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y 10.4%

Earnings Date Feb 25, 2026

EPS Estimate (next Q) $0.15

EPS Growth Est (next Q) -121.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $0.97

Graham Upside -81.9%

Lynch Fair Value $0.05

Lynch Upside -99.1%

Price Target $11.54

Price Target Upside 115.3%

Cash Flow

Operating Cash Flow $-52.13M

Free Cash Flow $-52.13M

Adj. Free Cash Flow $-14.89M

FCF Per Share -$0.09

OCF Per Share -$0.09

OCF/S Ratio -6.5%

Income Statement

Revenue $799.35M

Gross Profit $193.74M

Operating Income $123.8M

EBITDA $486.11M

Net Income $3.48M

EPS (Diluted) $0.01

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A

Dividends

Annual Dividend $0.36

Dividend Yield 6.72%

Payout Ratio 6545.4%

FCF Payout Ratio -27.1%

Adj. FCF Payout Ratio -95.1%

Dividend Growth (YoY) 12.5%

Pay Frequency Quarterly

Ex-Dividend Date Sep 9, 2026